Kalbitor
NDC 47783-101, Ecallantide, injection, solution, from Takeda Pharmaceuticals America, Inc..
- Product NDC
- 47783-101
- Status
- Listed
- Labeler
- Takeda Pharmaceuticals America, Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA125277
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/47783-101 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ECALLANTIDE10 mg/mL
Pharmacologic classes
Kallikrein Inhibitors [MoA]; Plasma Kallikrein Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 47783-101-01 | 47783010101 | 3 VIAL, GLASS in 1 CARTON (47783-101-01) / 1 mL in 1 VIAL, GLASS |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/f56aec67-c662-477c-b866-bfc23e8809cfMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=47783-101
Use it
Look up 47783-101 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/47783-101 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 47783-101. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.